Literature DB >> 22065565

Transgenic mice with SCA10 pentanucleotide repeats show motor phenotype and susceptibility to seizure: a toxic RNA gain-of-function model.

Misti White1, Guangbin Xia, Rui Gao, Maki Wakamiya, Partha S Sarkar, Karen McFarland, Tetsuo Ashizawa.   

Abstract

Spinocerebellar ataxia type 10 (SCA10) is an autosomal dominant neurodegenerative disorder manifested by ataxia and seizure. SCA10 is caused by a large expansion of an intronic ATTCT pentanucleotide repeat in the ATXN10 gene. We have recently postulated a toxic RNA-mediated gain of function in the pathogenesis of spinal cerebellar ataxia type 10 (SCA10). The spliced intron-9 RNA containing the expanded AUUCU repeat aggregates in SCA10 cells and sequesters hnRNP K. hnRNP K sequestration triggers the translocation of protein kinase Cδ (PKCδ) to mitochondria, leading to activation of caspase-3 and apoptosis. To confirm the toxic RNA-mediated gain of function, we generated a new transgenic mouse model in which the expanded pentanucleotide repeats are constructed in the 3'-untranslated region (3'UTR) to ensure transcription without translation of the repeat. We constructed an artificial transgene containing the SCA10 (ATTCT)(500) track within the 3'UTR of the LacZ gene driven by the rat prion promoter (PrP) and used this to generate a new transgenic mouse model for SCA10. We then examined these mice for neurological phenotypes and histopathological, molecular, and cellular changes. The transgenic mice showed irregular gait and increased seizure susceptibility at the age of 6 months, resembling the clinical phenotype of SCA10. The cerebral cortex, hippocampus, and pontine nuclei showed neuronal loss. The brains of these animals also showed molecular and cellular changes similar to those previously found in an SCA10 cell model. Expression of the expanded SCA10 AUUCU repeat within the 3'UTR of a gene results in neuronal loss with associated gait abnormalities and increased seizure susceptibility phenotypes, which resemble those seen in SCA10 patients. Moreover, these results bolster the idea that the SCA10 disease mechanism is mediated by a toxic RNA gain-of-function mutation of the expanded AUUCU repeat.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22065565      PMCID: PMC3307599          DOI: 10.1002/jnr.22786

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  23 in total

1.  Expansions, contractions, and fragility of the spinocerebellar ataxia type 10 pentanucleotide repeat in yeast.

Authors:  Nicole Cherng; Alexander A Shishkin; Lucas I Schlager; Ryan H Tuck; Laura Sloan; Robert Matera; Partha S Sarkar; Tetsuo Ashizawa; Catherine H Freudenreich; Sergei M Mirkin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

2.  Evidence against haploinsuffiency of human ataxin 10 as a cause of spinocerebellar ataxia type 10.

Authors:  Boris Keren; Aurélia Jacquette; Christel Depienne; Patricia Leite; Alexandra Durr; Wassila Carpentier; Baya Benyahia; Gerard Ponsot; Florent Soubrier; Alexis Brice; Delphine Héron
Journal:  Neurogenetics       Date:  2009-11-20       Impact factor: 2.660

3.  The role of ataxin 10 in the pathogenesis of spinocerebellar ataxia type 10.

Authors:  M Wakamiya; T Matsuura; Y Liu; G C Schuster; R Gao; W Xu; P S Sarkar; X Lin; T Ashizawa
Journal:  Neurology       Date:  2006-08-22       Impact factor: 9.910

4.  Interruptions in the expanded ATTCT repeat of spinocerebellar ataxia type 10: repeat purity as a disease modifier?

Authors:  Tohru Matsuura; Ping Fang; Christopher E Pearson; Parul Jayakar; Tetsuo Ashizawa; Benjamin B Roa; David L Nelson
Journal:  Am J Hum Genet       Date:  2005-11-15       Impact factor: 11.025

5.  Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10.

Authors:  T Matsuura; T Yamagata; D L Burgess; A Rasmussen; R P Grewal; K Watase; M Khajavi; A E McCall; C F Davis; L Zu; M Achari; S M Pulst; E Alonso; J L Noebels; D L Nelson; H Y Zoghbi; T Ashizawa
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

Review 6.  Pathogenic mechanisms of myotonic dystrophy.

Authors:  Johanna E Lee; Thomas A Cooper
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

Review 7.  Tests to assess motor phenotype in mice: a user's guide.

Authors:  Simon P Brooks; Stephen B Dunnett
Journal:  Nat Rev Neurosci       Date:  2009-06-10       Impact factor: 34.870

8.  Inactivation of hnRNP K by expanded intronic AUUCU repeat induces apoptosis via translocation of PKCdelta to mitochondria in spinocerebellar ataxia 10.

Authors:  Misti C White; Rui Gao; Weidong Xu; Santi M Mandal; Jung G Lim; Tapas K Hazra; Maki Wakamiya; Sharon F Edwards; Salmo Raskin; Hélio A G Teive; Huda Y Zoghbi; Partha S Sarkar; Tetsuo Ashizawa
Journal:  PLoS Genet       Date:  2010-06-10       Impact factor: 5.917

9.  Ataxin 10 induces neuritogenesis via interaction with G-protein beta2 subunit.

Authors:  Masaaki Waragai; Shinichiro Nagamitsu; Weidong Xu; Yu Jiang Li; Xi Lin; Tetsuo Ashizawa
Journal:  J Neurosci Res       Date:  2006-05-15       Impact factor: 4.164

10.  A novel cell death pathway that is partially caspase dependent, but morphologically non-apoptotic, elicited by proteasomal inhibition of rat sympathetic neurons.

Authors:  Isabelle Lang-Rollin; Georgia Dermentzaki; Kostas Vekrellis; Maria Xilouri; Hardy J Rideout; Leonidas Stefanis
Journal:  J Neurochem       Date:  2008-01-08       Impact factor: 5.372

View more
  25 in total

1.  Bolivian kindred with combined spinocerebellar ataxia types 2 and 10.

Authors:  J F Baizabal-Carvallo; G Xia; P Botros; J Laguna; T Ashizawa; J Jankovic
Journal:  Acta Neurol Scand       Date:  2015-01-28       Impact factor: 3.209

Review 2.  Pre-mRNA splicing in disease and therapeutics.

Authors:  Ravi K Singh; Thomas A Cooper
Journal:  Trends Mol Med       Date:  2012-07-18       Impact factor: 11.951

Review 3.  Protein sequestration as a normal function of long noncoding RNAs and a pathogenic mechanism of RNAs containing nucleotide repeat expansions.

Authors:  Ginny R Morriss; Thomas A Cooper
Journal:  Hum Genet       Date:  2017-05-08       Impact factor: 4.132

4.  Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures.

Authors:  Karen N McFarland; Jilin Liu; Ivette Landrian; Desmond Zeng; Salmo Raskin; Mariana Moscovich; Emilia M Gatto; Adriana Ochoa; Hélio A G Teive; Astrid Rasmussen; Tetsuo Ashizawa
Journal:  Neurogenetics       Date:  2013-12-07       Impact factor: 2.660

Review 5.  The autosomal dominant spinocerebellar ataxias: emerging mechanistic themes suggest pervasive Purkinje cell vulnerability.

Authors:  Katherine E Hekman; Christopher M Gomez
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-08-18       Impact factor: 10.154

6.  Paradoxical effects of repeat interruptions on spinocerebellar ataxia type 10 expansions and repeat instability.

Authors:  Karen N McFarland; Jilin Liu; Ivette Landrian; Rui Gao; Partha S Sarkar; Salmo Raskin; Mariana Moscovich; Emilia M Gatto; Hélio A G Teive; Adriana Ochoa; Astrid Rasmussen; Tetsuo Ashizawa
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

Review 7.  Polyglutamine spinocerebellar ataxias - from genes to potential treatments.

Authors:  Henry L Paulson; Vikram G Shakkottai; H Brent Clark; Harry T Orr
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

8.  Purkinje cell loss is the major brain pathology of spinocerebellar ataxia type 10.

Authors:  Guangbin Xia; Karen N McFarland; Kang Wang; Partha S Sarkar; Anthony T Yachnis; Tetsuo Ashizawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-06-29       Impact factor: 10.154

Review 9.  RNA-binding protein misregulation in microsatellite expansion disorders.

Authors:  Marianne Goodwin; Maurice S Swanson
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 10.  Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean.

Authors:  Roberto Rodríguez-Labrada; Ana Carolina Martins; Jonathan J Magaña; Yaimeé Vazquez-Mojena; Jacqueline Medrano-Montero; Juan Fernandez-Ruíz; Bulmaro Cisneros; Helio Teive; Karen N McFarland; Maria Luiza Saraiva-Pereira; César M Cerecedo-Zapata; Christopher M Gomez; Tetsuo Ashizawa; Luis Velázquez-Pérez; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2020-06       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.